| 2024 | Early Implementation of Exercise to Facilitate Recovery After Breast Cancer Surgery: A Randomized Clinical Trial | JAMA SURGERY |
| 2024 | Breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA study
| INTERNATIONAL JOURNAL OF SURGERY |
| 2024 | Prediction of a Multi-Gene Assay (Oncotype DX and Mammaprint) Recurrence Risk Group Using Machine Learning in Estrogen Receptor-Positive, HER2-Negative Breast Cancer-The BRAIN Study
| CANCERS |
| 2023 | A simplified risk scoring system for predicting high-risk groups in gene expression tests for patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative, and node-positive breast cancer
| ANNALS OF SURGICAL TREATMENT AND RESEARCH |
| 2023 | Lymphovascular invasion is an independent prognostic factor in breast cancer irrespective of axillary node metastasis and molecular subtypes
| FRONTIERS IN ONCOLOGY |
| 2023 | Distinct Prognosis of Minimal Residual Disease According to Breast Cancer Subtype in Patients with Breast or Nodal Pathologic Complete Response After Neoadjuvant Chemotherapy | ANNALS OF SURGICAL ONCOLOGY |
| 2023 | Oncologic Outcomes in Nipple-sparing Mastectomy with Immediate Reconstruction and Total Mastectomy with Immediate Reconstruction in Women with Breast Cancer: A Machine-Learning Analysis | ANNALS OF SURGICAL ONCOLOGY |
| 2023 | Multidisciplinary Shared Decision Making for Fertility Preservation in Young Women With Breast Cancer
| JOURNAL OF BREAST CANCER |
| 2023 | Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor-Positive Metastatic Breast Cancer
| CANCER RESEARCH AND TREATMENT |
| 2023 | Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer | JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE |
| 2023 | Hematologic toxicities, sarcopenia, and body composition change in breast cancer patients undergoing neoadjuvant chemotherapy | SUPPORTIVE CARE IN CANCER |
| 2023 | Fertility Preservation in Young Women With Breast Cancer: A Review
| JOURNAL OF BREAST CANCER |
| 2023 | Shoulder function and health outcomes in newly diagnosed breast cancer patients receiving surgery: a prospective study | CLINICAL BREAST CANCER |
| 2023 | Changes in Automated Mammographic Breast Density Can Predict Pathological Response After Neoadjuvant Chemotherapy in Breast Cancer
| KOREAN JOURNAL OF RADIOLOGY |
| 2023 | Effect of a 1-year tailored exercise program according to cancer trajectories in patients with breast cancer: study protocol for a randomized controlled trial
| BMC CANCER |
| 2023 | On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates
| BREAST CANCER RESEARCH |
| 2022 | Does neoadjuvant chemotherapy regimen affect sarcopenia status in patients with breast cancer?
| BREAST |
| 2022 | Survival of women with pregnancy-associated breast cancer according to clinical characteristics: A propensity score matching study
| MEDICINE |
| 2022 | Lobular Carcinoma In Situ during Preoperative Biopsy and the Rate of Upgrade
| CANCER RESEARCH AND TREATMENT |
| 2022 | Blood Test for Breast Cancer Screening through the Detection of Tumor-Associated Circulating Transcripts
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2022 | Body composition change during neoadjuvant chemotherapy for breast cancer
| FRONTIERS IN ONCOLOGY |
| 2022 | The Risk Factors, Incidence and Prognosis of Postpartum Breast Cancer: A Nationwide Study by the SMARTSHIP Group
| FRONTIERS IN ONCOLOGY |
| 2022 | Tearing down the barriers to exercise after mastectomy: a qualitative inquiry to facilitate exercise among breast cancer survivors
| BMJ OPEN |
| 2022 | RT-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with breast cancer indicate poor prognosis | BREAST CANCER RESEARCH AND TREATMENT |
| 2022 | Relationship Between Breast and Axillary Pathologic Complete Response According to Clinical Nodal Stage: A Nationwide Study From Korean Breast Cancer Society
| JOURNAL OF BREAST CANCER |
| 2022 | Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen? | BREAST CANCER RESEARCH AND TREATMENT |
| 2022 | Effects of a partnership-based, needs-tailored self-management support intervention for post-treatment breast cancer survivors: A randomized controlled trial | PSYCHO-ONCOLOGY |
| 2022 | No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial
| BMC CANCER |
| 2021 | The Impact of Post-Mastectomy Radiotherapy on Survival Outcomes in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy
| CANCERS |
| 2021 | Level of Combined Estrogen and Progesterone Receptor Expression Determines the Eligibility for Adjuvant Endocrine Therapy in Breast Cancer Patients
| CANCERS |
| 2021 | Axillary response according to neoadjuvant single or dual human epidermal growth factor receptor 2 (HER2) blockade in clinically node-positive, HER2-positive breast cancer
| INTERNATIONAL JOURNAL OF CANCER |
| 2021 | Change in Shoulder Function in the Early Recovery Phase after Breast Cancer Surgery: A Prospective Observational Study
| JOURNAL OF CLINICAL MEDICINE |
| 2021 | Time-Sequencing of the Neutrophil-to-Lymphocyte Ratio to Predict Prognosis of Triple-Negative Breast Cancer
| CANCERS |
| 2021 | Clinicopathological Features and Prognosis of Lobular Carcinoma In Situ
| Journal of Breast Disease |
| 2021 | Preoperative Routine Laboratory Markers for Predicting Postoperative Recurrence and Death in Patients with Breast Cancer
| JOURNAL OF CLINICAL MEDICINE |
| 2021 | Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer
| FRONTIERS IN ONCOLOGY |
| 2021 | Genomic landscape of extraordinary responses in metastatic breast cancer
| COMMUNICATIONS BIOLOGY |
| 2021 | Post-Operative Complications and Nipple Necrosis Rates Between Conventional and Robotic Nipple-Sparing Mastectomy
| FRONTIERS IN ONCOLOGY |
| 2021 | Survival Rates of Breast Cancer Patients Aged 40 to 49 Years according to Detection Modality in Korea: Screening Ultrasound versus Mammography
| KOREAN JOURNAL OF RADIOLOGY |
| 2020 | Validation of Clinical Treatment Score post-5 years (CTS5) risk stratification in premenopausal breast cancer patients and Ki-67 labelling index
| SCIENTIFIC REPORTS |
| 2020 | Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
| 2020 | Prognostic value of neutrophil-to-lymphocyte ratio in human epidermal growth factor receptor 2-negative breast cancer patients who received neoadjuvant chemotherapy
| SCIENTIFIC REPORTS |
| 2020 | Optimal treatment of pseudoangiomatous stromal hyperplasia of the breast
| ASIAN JOURNAL OF SURGERY |
| 2020 | Radiotherapy-Induced High Neutrophil-to-Lymphocyte Ratio is a Negative Prognostic Factor in Patients with Breast Cancer
| CANCERS |
| 2020 | Dietary advanced glycation end products and the risk of postmenopausal breast cancer in the National Institutes of Health-AARP Diet and Health Study | CANCER |
| 2020 | Conserving the lymphatics from the arm using fluorescence imaging in patients with breast cancer at high risk of postoperative lymphedema: a pilot study
| GLAND SURGERY |
| 2020 | Validating Breast Cancer Risk Prediction Models in the Korean Cancer Prevention Study-II Biobank | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION |
| 2020 | Design of a randomized controlled trial of a partnership-based, needs-tailored self-management support intervention for post-treatment breast cancer survivors
| BMC CANCER |
| 2020 | Intermediate HER2 Expression Is Associated With Poor Prognosis in Estrogen Receptor-Positive Breast Cancer Patients Aged 55 Years and Older | BREAST CANCER RESEARCH AND TREATMENT |
| 2019 | Establishment of Chemosensitivity Tests in Triple-Negative and BRCA-mutated Breast Cancer Patient-Derived Xenograft Models
| PLOS ONE |
http://orcid.org/0000-0001-8089-2755
(55717320100)
